Seronegative Lyme Disease

New England Journal of Medicine

Volumn 319, Issue 22, 1988, Pages 1441-1446

  Dattwyler, Raymond J ^a   Volkman, David J ^a   Luft, Benjamin J ^a   Halperin, John J ^a   Thomas, Josephine ^a   Golightly, Marc G ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; BORRELIA BURGDORFERI; CELLULAR IMMUNITY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; LYME DISEASE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BLOTTING, WESTERN; BORRELIA; CHILD; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOENZYME TECHNIQUES; LYME DISEASE; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0023736053     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198812013192203     Document Type: Article

References (49)

1. Afzelius A. Verhandlungen der dermatologischen Gesellschaft zu Stockholm: Sitzung vom 28. Oktober 1909. Arch Dermatol Syph 1910; 101: 403–4.
2. Hellerström S. Erythema chronicum migrans Afzelius with meningitis. Acta Derm Venereol (Stockh) 1951; 31: 227–34.
3. Weber K. Erythema-chronicum-migrans-meningitis — eine bakterielle Infektiontionskrankheit? Munch Med Wochenschr 1974; 116: 1993–8.
4. Steere Achéal, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA. Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum. Ann Intern Med 1977; 86: 685–98.
5. Leczinsky CG. Case of erythema chronicum migrans with meningitis. Acta Derm Venereol (Stockh) 1951; 31: 464–7.
6. Bannwarth A. Chronische lymphocytäre Meningitis, entzündliche Polyneuritis und Rheumatismus. Arch Psychiatr Nervenkr 1941; 113: 284–376.
7. Malawista SE, Steere Achéal. Lyme disease: infectious in origin, rheumatic in expression. Adv Intern Med 1986; 31: 147–66.
8. Ackermann R, Runne U, Klenk W, Dienst C. Erythema chronicum migrans mit Arthritis. Dtsch Med Wochenschr 1980; 105: 1779–81.
9. Stiernstedt G, Sköldenberg B, Gårde A, et al. Clinical manifestations of Borrelia infections of the nervous system. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986; 263: 289–96.
10. Wokke JH, Van Gijn J, Elderson A, Stanek G. Chronic forms of Borrelia burgdorferi infection of the nervous system. Neurology 1987; 37: 1031–4.
11. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease — a tick-borne spirochetosis? Science 1982; 216: 1317–9.
12. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 1983; 308: 740–2.
13. Steere Achéal, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983; 308: 733–40.
14. Asbrink E, Hederstedt B, Hovmark A. The spirochetal etiology of erythema chronicum migrans Afzelius. Acta Derm Venereol 1984; 64: 291–5.
15. Stiernstedt G, Eriksson G, Enfors W, et al. Erythema chronicum migrans in Sweden: clinical manifestations and antibodies to Ixodes ricinus spirochete measured by indirect immunofluorescence and enzyme-linked immunosorbent assay. Scand J Infect Dis 1986; 18: 217–24.
16. Johnston YE, Duray PH, Steere Achéal, et al. Lyme arthritis: spirochetes found in synovial microangiopathic lesions. Am J Pathol 1985; 118: 26–34.
17. Lastavica CC, Snydman DR, Schenkein DP, Berardi VP, Pariser KM. Demonstration of Borrelia burgdorferi in a patient with chronic Lyme arthritis. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986; 263: 288.
18. Steere Achéal, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med 1983; 99: 22–6.
19. Craft JE, Grodzicki RL, Steere Achéal. Antibody response in Lyme disease: evaluation of diagnostic tests. J Infect Dis 1984; 149: 789–95.
20. Craft JE, Fischer DK, Shimamoto GT, Steere Achéal. Antigens of Borrelia burgdorferi recognized during Lyme disease: appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest 1986; 78: 934–9.
21. Dattwyler RJ, Halperin JJ. Failure of tetracycline therapy in early Lyme disease. Arthritis Rheum 1987; 30: 448–50.
22. Dattwyler RJ, Thomas JA, Benach JL, Golightly MG. Cellular immune response in Lyme disease: the response to mitogens, live Borrelia burgdorferi, NK cell function and lymphocyte subsets. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986; 263: 151–9.
23. Dattwyler RJ, Volkman DJ, Halperin JJ, Luft BJ, Thomas J, Golightly MG. T and B cell immune responses in Borrelia burgdorferi infection. Ann NY Acad Sci 1988; 539: 93–102.
24. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4.
25. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984; 57: 521–5.
26. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54.
27. Halperin JJ, Pass HL, Anand AK, Luft BJ, Volkman DJ, Dattwyler RJ. Nervous system abnormalities in Lyme disease. Ann NY Acad Sci 1988; 539: 24–34.
28. DeFilippis NA, McCampbell E, Rogers P. Development of a booklet form of the Category Test: normative and validity data. J Clin Neuropsychol 1979; 1: 339–42.
29. Dattwyler RJ, Thomas J, Hurst LD. Antigen-specific T-cell anergy in progressive Mycobacterium marinum infection in humans. Ann Intern Med 1987; 107: 675–7.
30. Stobo JD, Paul S, Van Scoy RE, Hermans PE. Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest 1976; 57: 319–28.
31. Mehra V, Mason LH, Fields JP, Bloom BR. Lepromin-induced suppressor cells in patients with leprosy. J Immunol 1979; 123: 1813–7.
32. Bloom BR. Games parasites play: how parasites evade immune surveillance. Nature 1979; 279: 21–6.
33. Piessens WF, Ratiwayanto S, Tuti S, et al. Antigen-specific suppressor cells and suppressor factors in human filariasis with Brugia malayi. N Engl J Med 1980; 302:833–7.
34. Letvin NL, Benacerraf B, Germain RN. B-lymphocyte responses to trinitrophenyl conjugated Ficoll: requirement for T lymphocytes and la-bearing adherent cells. Proc Natl Acad Sci USA 1981; 78: 5113–7.
35. Fitzgerald TJ. Pathogenesis and immunology of Treponema pallidum. Annu Rev Microbiol 1981; 35: 29–54.
36. Stites DP, Stobo JD, Wells JV, Fahey JL. Basic and clinical immunology. 6th ed. Norwalk, Conn.: Appleton & Lange, 1987:688.
37. Benacerraf B. Role of MHC gene products in immune regulation. Science 1981; 212: 1229–38.
38. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature 1985; 314: 537–9.
39. Preac-Mursic V, Wilske B, Schierz G. European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986; 263: 112–8.
40. Luft BJ, Dattwyler RJ, Halperin JJ, Volkman DJ. New chemotherapeutic approaches to the treatment of Lyme borreliosis. Ann NY Acad Sci 1988; 539: 352–61.
41. Moskovitz BL, Klimek JJ, Goldman RL, Fiumara NJ, Quintiliani R. Meningovascular syphilis after “appropriate” treatment of primary syphilis. Arch Intern Med 1982; 142: 139–40.
42. Bayne LL, Schmidley JW, Goodin DS. Acute syphilitic meningitis: its occurrence after clinical and serologic cure of secondary syphilis with penicillin G. Arch Neurol 1986; 43: 137–8.
43. Markovitz DM, Beutner KR, Maggio RP, Reichman RC. Failure of recommended treatment for secondary syphilis. JAMA 1986; 255: 1767–8.
44. Stiernstedt G, Karlsson M, Sköldenberg B, Svenungsson B, Gustafsson R. Clinical manifestations and diagnosis of Borrelia meningitis. Ann NY Acad Sci 1988; 539: 46–55.
45. Bateman DE, Lawton NF, White JE, Greenwood RJ, Wright DJ. The neurological complications of Borrelia burgdorferi in the New Forest area of Hampshire. J Neurol Neurosurg Psychiatry 1988; 51: 699–703.
46. Hansen K, Hindersson P, Pedersen NS. Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease. J Clin Microbiol 1988; 26: 338–46.
47. Halperin JJ, Little BW, Coyle PK, Dattwyler RJ. Lyme disease: cause of a treatable peripheral neuropathy. Neurology 1987; 37: 1700–6.
48. Dattwyler RJ, Halperin JJ, Pass H, Luft BJ. Ceftriaxone as effective therapy in refractory Lyme disease. J Infect Dis 1987; 155: 1322–5.
49. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme borreliosis — randomised comparison of ceftriaxone and penicillin. Lancet 1988; 1: 1191–4.